Sponsored diagnostic testing programs for Andersen-Tawil Syndrome (ATS)
Andersen–Tawil Syndrome (ATS) is a rare genetic disorder characterized by episodic muscle weakness, cardiac arrhythmias such as prolonged QT or ventricular ectopy, and distinctive physical features. Symptoms vary widely, and genetic testing can help confirm the diagnosis by identifying pathogenic variants in potassium channel genes.
2 programs found for Andersen-Tawil Syndrome (ATS)
The Invitae Unlock™ Cardiomyopathy & Arrhythmia program offers no-charge genetic testing for U.S. patients with suspected inherited cardiomyopathy or arrhythmia. The comprehensive panel supports diagnostic clarification, risk assessment, and family variant identification. Eligible patients may access testing at no cost when ordered by a qualified healthcare provider.
The Uncovering Periodic Paralysis Program offers no-cost genetic testing and genetic counseling for individuals with episodic muscle weakness or temporary paralysis often triggered by common factors associated with primary hyperkalemic or hypokalemic periodic paralysis. This testing program is sponsored by Xeris Pharmaceuticals.
